Single and multiple doses of Indacaterol, a novel once-daily β2-agonists, are well tolerated in patients with mild asthma

被引：0

作者：

Brookman, L

Knight, H

Wood, J

Perry, S

Tarral, A

Elharrar, B

Pascoe, S

机构：

[1] Novartis Horsham Res Ctr, Horsham, W Sussex, England

[2] Biotrial, Paris, France

[3] Aster Cephac, Paris, France

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2005.12.333

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

324

引用

页码：S83 / S83

页数：1

共 50 条

[1] Indacaterol, a novel once-daily β2-agonist, demonstrates 24-hour efficacy and is well tolerated in patients with persistent
Kanniess, F
Cameron, R
Owen, R
Higgins, M
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S196 - S197
[2] Once-Daily Tiotropium Is Well Tolerated as Add-On to Standard Treatment for Patients With Symptomatic Asthma Despite Receiving Inhaled Corticosteroids and Long-Acting β2-Agonists
Bernstein, Jonathan A.
Kerstjens, Huib A. M.
Moroni-Zentgraf, Petra
Engel, Michael
Schmidt, Hendrik
Halpin, David M. G.
CHEST, 2013, 144 (04)
[3] Bronchodilator efficacy of indacaterol, a novel once-daily β2-agonist, in patients with persistent asthma
Pearlman, David S.
Greos, Leon
LaForce, Craig
Orevillo, Chadwick J.
Owen, Roger
Higgins, Mark
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 101 (01) : 90 - 95
[4] Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma
Pearlman, DS
Berger, WE
Kerwin, E
LaForce, C
Kundu, S
Banerji, D
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (06) : 1206 - 1212
[5] Long term use of once-daily mometasone furoate is effective and well tolerated in patients with mild to moderate persistent asthma
Nayak, AS
Lampl, KL
Segall, N
Harrison, J
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S98 - S98
[6] Safety of indacaterol, a novel once-daily β2-agonist, in persistent asthma.
Yang, W.
Higgins, M.
Cameron, R.
Owen, R.
Yegen, U.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A79 - A79
[7] Pulmicort Turbuhaler - Once-daily dosing for patients with mild to moderate asthma
不详
FORMULARY, 1999, 34 (01) : 14 - +
[8] Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily β2-agonist bronchodilator, in subjects with COPD
Pascoe, S.
Reynolds, C.
Pleskow, W.
Perry, S.
Hmissi, A.
Kaiser, G.
Brookman, L.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (02) : 153 - 161
[9] Once-Daily Tiotropium Reduces Risk of Exacerbations and Asthma Worsening in Patients With Symptomatic Asthma Despite Treatment With Inhaled Corticosteroids and Long-Acting β2-Agonists
Tashkin, Donald P.
Moroni-Zentgraf, Petra
Engel, Michael
Schmidt, Hendrik
Kerstjens, Huib A. M.
CHEST, 2013, 144 (04)
[10] Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD
Lorraine Murphy
Stephen Rennard
James Donohue
Mathieu Molimard
Ronald Dahl
Kai-Michael Beeh
Juergen Dederichs
Hans-Jürgen Fülle
Mark Higgins
David Young
Drugs, 2014, 74 : 1635 - 1657

← 1 2 3 4 5 →